Skip to content
healthcare.dev

PYLERA

NDC 61269-381, BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE, capsule, from H2-Pharma, LLC.

Product NDC
61269-381
Status
Listed
Labeler
H2-Pharma, LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA050786
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61269-381 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BISMUTH SUBCITRATE POTASSIUM140 mg/1
  • METRONIDAZOLE125 mg/1
  • TETRACYCLINE HYDROCHLORIDE125 mg/1

Pharmacologic classes

Bismuth [CS]; Bismuth [EPC]; Nitroimidazole Antimicrobial [EPC]; Nitroimidazoles [CS]; Tetracycline-class Antimicrobial [EPC]; Tetracyclines [CS]

Package NDCNDC-11Package
61269-381-126126903811210 BLISTER PACK in 1 BOX (61269-381-12) / 12 CAPSULE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c50626a2-5969-490b-a88a-a4ee45e79615
  • NADAC price for package 61269038112

    GET /v1/drugs/nadac/61269038112

Use it

Look up 61269-381 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61269-381 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61269-381. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.